Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 121 - 150 of 210
<  Previous 30    |  1  2  3  4  5  6  7  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
		European Medicines Agency's website: Nimvastid - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Ninlaro - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Nintedanib Accord - EMA: EPAR PI Finnish Swedish
PL	Resepti	Nintedanib ratiopharm 100 mg, 150 mg kapseli, pehmeä SPC 2024-01-17
PL	Resepti	Nintedanib Sandoz 100 mg, 150 mg kapseli, pehmeä SPC 2024-11-05
PL	Resepti	Nintedanib STADA 100 mg, 150 mg kapseli, pehmeä SPC 2024-01-10
PL	Resepti	Nintedanib Zentiva 100 mg, 150 mg kapseli, pehmeä SPC 2024-01-25
PL	Resepti	Niontix 100% lääkkeellinen kaasu, nesteytetty SPC 2020-06-09
PL	Resepti	Nipruss 60 mg infuusiokuiva-aine, liuosta varten SPC 2024-04-24
PL	Resepti	Nitisinone Dipharma 2 mg, 20 mg kapseli, kova SPC 2024-06-11
PL	Resepti	Nitisinone Dipharma 5 mg, 10 mg kapseli, kova SPC 2024-06-11
		European Medicines Agency's website: Nitisinone MDK - EMA: EPAR PI Finnish Swedish
PL	Resepti	Nitrazepam Accord 5 mg tabletti SPC 2022-03-30
PL	Resepti	Nitrofur-C 75 mg kalvopäällysteinen tabletti SPC 2020-09-21
PL	Resepti	Nitrofurantoin PharmSol 50 mg, 100 mg kapseli, kova SPC 2024-05-24
PL	Resepti	Nitroglycerin Orifarm 0.5 mg resoribletti SPC 2024-03-12
PL	Resepti	Nitrosid 5 mg, 10 mg, 20 mg tabletti SPC 2020-07-29
PL	Resepti	Nitrosid Retard 20 mg depotkapseli, kova SPC 2020-12-09
		European Medicines Agency's website: Nivestim - EMA: EPAR PI Finnish Swedish
PL	Resepti	Nix 5 prosenttinen emulsiovoide SPC 2024-08-12
PL	Itsehoito	Nix shampoo SPC 2022-02-03
PL	Itsehoito	Nizoral 2 prosenttinen emulsiovoide SPC 2024-01-30
PL	Itsehoito	Nizoral 20 mg-ml shampoo SPC 2021-08-20
PL	Resepti	Nocdurna 25 mikrog ja 50 mikrog tabletti, kylmäkuivattu SPC 2021-05-05
PL	Resepti	Nocedan 5 mg tabletti, kalvopäällysteinen SPC 2023-08-10
PL	Resepti	Nomigrin 85 mg / 500 mg tabletti, kalvopäällysteinen SPC 2024-10-11
PL	Resepti	Nootropil 1200 mg tabletti, kalvopäällysteinen SPC 2022-01-28
PL	Resepti	Noradrenalin Abcur 1 mg-ml infuusiokonsentraatti, liuosta varten SPC 2021-11-11
PL	Resepti	Noradrenalin Aguettant 0.08 mg-ml infuusioneste, liuos SPC 2022-10-07
PL	Resepti	Noradrenalin Fresenius Kabi 1 mg-ml infuusiokonsentraatti, liuosta varten SPC 2021-10-06
<  Previous 30    |  1  2  3  4  5  6  7  |  Next 30   >